Olfactory Bulbectomy Model of Depression Lowers Responding for Food in Male and Female Rats: The Modulating Role of Caloric Restriction and Response Requirement
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
MUNI/A/1342/2022
Ministry of Education Youth and Sports
PubMed
37760922
PubMed Central
PMC10525806
DOI
10.3390/biomedicines11092481
PII: biomedicines11092481
Knihovny.cz E-zdroje
- Klíčová slova
- depression, olfactory bulbectomy, reward, self-administration, sex, strain,
- Publikační typ
- časopisecké články MeSH
Depression is a psychiatric disorder characterized by a marked decrease in reward sensitivity. By using the olfactory bulbectomy (OBX) model of depression, it was shown that OBX rats display enhanced drug-taking and seeking behaviors in a self-administration paradigm than sham-operated (SHAM) controls, and sex is an important regulating factor. To reveal potential strain effects, we compared the operant behavior of male and female Sprague-Dawley and Wistar OBX and SHAM rats trained to self-administer palatable food pellets. Results showed that Sprague-Dawley OBX rats of both sexes exhibited lower operant responding rates and food intake than SHAM controls. Food restriction increased responding in both OBX and SHAM groups. Female rats responded more than males, but the OBX lesion abolished this effect. In Wistar rats, bulbectomy lowered food self-administration only during the last training days. Food self-administration was not significantly affected in Wistar rats by sex. In summary, this study showed that bulbectomy significantly reduces operant responding and food intake in male and female Sprague-Dawley rats while inducing a mild reducing effect only in the Wistar strain. Strain-dependent effects were also observed in the modulating role of sex and food restriction on operant responding and palatable food intake.
CNR Institute of Neuroscience Cagliari National Research Council 09042 Monserrato CA Italy
Department of Pharmacology Faculty of Medicine Masaryk University 62500 Brno Czech Republic
Zobrazit více v PubMed
Wang S., Leri F., Rizvi S.J. Anhedonia as a Central Factor in Depression: Neural Mechanisms Revealed from Preclinical to Clinical Evidence. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;110:110289. doi: 10.1016/j.pnpbp.2021.110289. PubMed DOI
Hao Y., Ge H., Sun M., Gao Y. Selecting an Appropriate Animal Model of Depression. Int. J. Mol. Sci. 2019;20:4827. doi: 10.3390/ijms20194827. PubMed DOI PMC
Harro J. Animal Models of Depression: Pros and Cons. Cell Tissue Res. 2019;377:5–20. doi: 10.1007/s00441-018-2973-0. PubMed DOI
Czeh B., Fuchs E., Wiborg O., Simon M. Animal Models of Major Depression and Their Clinical Implications. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2015;64:293–310. doi: 10.1016/j.pnpbp.2015.04.004. PubMed DOI
Song C., Leonard B.E. The Olfactory Bulbectomised Rat as a Model of Depression. Neurosci. Biobehav. Rev. 2005;29:627–647. doi: 10.1016/j.neubiorev.2005.03.010. PubMed DOI
Harkin A., Kelly J.P., Leonard B.E. A Review of the Relevance and Validity of Olfactory Bulbectomy as a Model of Depression. Clin. Neurosci. Res. 2003;3:253–262. doi: 10.1016/S1566-2772(03)00087-2. DOI
Abelaira H.M., Réus G.Z., Quevedo J. Animal Models as Tools to Study the Pathophysiology of Depression. Rev. Bras. Psiquiatr. 2013;35((Suppl. S2)):S112–S120. doi: 10.1590/1516-4446-2013-1098. PubMed DOI
Zhu H., Tao Y., Wang T., Zhou J., Yang Y., Cheng L., Zhu H., Zhang W., Huang F., Wu X. Long-Term Stability and Characteristics of Behavioral, Biochemical, and Molecular Markers of Three Different Rodent Models for Depression. Brain Behav. 2020;10:e01508. doi: 10.1002/brb3.1508. PubMed DOI PMC
Morales-Medina J.C., Iannitti T., Freeman A., Caldwell H.K. The Olfactory Bulbectomized Rat as a Model of Depression: The Hippocampal Pathway. Behav. Brain Res. 2017;317:562–575. doi: 10.1016/j.bbr.2016.09.029. PubMed DOI
Rajkumar R., Dawe G.S. OBscure but Not OBsolete: Perturbations of the Frontal Cortex in Common between Rodent Olfactory Bulbectomy Model and Major Depression. J. Chem. Neuroanat. 2018;91:63–100. doi: 10.1016/j.jchemneu.2018.04.001. PubMed DOI
Wang D., Noda Y., Tsunekawa H., Zhou Y., Miyazaki M., Senzaki K., Nabeshima T. Behavioural and Neurochemical Features of Olfactory Bulbectomized Rats Resembling Depression with Comorbid Anxiety. Behav. Brain Res. 2007;178:262–273. doi: 10.1016/j.bbr.2007.01.003. PubMed DOI
Filip M., Frankowska M., Jastrzebska J., Wydra K., Przegalinski E. Preclinical Studies on Comorbidity between Depression and Psychostimulant Addiction. Pharmacol. Rep. 2013;65:1529–1534. doi: 10.1016/S1734-1140(13)71514-7. PubMed DOI
Lieb R. Epidemiological Perspectives on Comorbidity Between Substance Use Disorders and Other Mental Disorders. In: Dom G., Moggi F., editors. Co-Occurring Addictive and Psychiatric Disorders: A Practice-Based Handbook from a European Perspective. Springer; Berlin/Heidelberg, Germany: 2015. pp. 3–12.
Torrens M., Rossi P. Mood Disorders and Addiction. In: Dom G., Moggi F., editors. Co-Occurring Addictive and Psychiatric Disorders. A Practice-Based Handbook from a European Perspective. Springer; New York, NY, USA: 2015. pp. 103–117.
Ortiz-Gomez L.D., Lopez-Canul B., Arankowsky-Sandoval G. Factors Associated with Depression and Suicide Attempts in Patients Undergoing Rehabilitation for Substance Abuse. J. Affect. Disord. 2014;169:10–14. doi: 10.1016/j.jad.2014.07.033. PubMed DOI
Holmes P.V., Masini C.V., Primeaux S.D., Garrett J.L., Zellner A., Stogner K.S., Duncan A.A., Crystal J.D. Intravenous Self-Administration of Amphetamine Is Increased in a Rat Model of Depression. Synapse. 2002;46:4–10. doi: 10.1002/syn.10105. PubMed DOI
Babinska Z., Ruda-Kucerova J. Differential Characteristics of Ketamine Self-Administration in the Olfactory Bulbectomy Model of Depression in Male Rats. Exp. Clin. Psychopharmacol. 2017;25:84–93. doi: 10.1037/pha0000106. PubMed DOI
Kucerova J., Pistovcakova J., Vrskova D., Dusek L., Sulcova A. The Effects of Methamphetamine Self-Administration on Behavioural Sensitization in the Olfactory Bulbectomy Rat Model of Depression. Int. J. Neuropsych. 2012;15:1503–1511. doi: 10.1017/S1461145711001684. PubMed DOI
Amchova P., Kucerova J., Giugliano V., Babinska Z., Zanda M., Scherma M., Dusek L., Fadda P., Micale V., Sulcova A., et al. Enhanced Self-Administration of the CB1 Receptor Agonist WIN55,212-2 in Olfactory Bulbectomized Rats: Evaluation of Possible Serotonergic and Dopaminergic Underlying Mechanisms. Front. Pharmacol. 2014;5:44. doi: 10.3389/fphar.2014.00044. PubMed DOI PMC
Frankowska M., Jastrzebska J., Nowak E., Bialko M., Przegalinski E., Filip M. The Effects of N-Acetylcysteine on Cocaine Reward and Seeking Behaviors in a Rat Model of Depression. Behav. Brain Res. 2014;266:108–118. doi: 10.1016/j.bbr.2014.02.044. PubMed DOI
Vieyra-Reyes P., Mineur Y.S., Picciotto M.R., Tunez I., Vidaltamayo R., Drucker-Colin R. Antidepressant-like Effects of Nicotine and Transcranial Magnetic Stimulation in the Olfactory Bulbectomy Rat Model of Depression. Brain Res. Bull. 2008;77:13–18. doi: 10.1016/j.brainresbull.2008.05.007. PubMed DOI PMC
Siska F., Amchova P., Kuruczova D., Tizabi Y., Ruda-Kucerova J. Effects of Low-Dose Alcohol Exposure in Adolescence on Subsequent Alcohol Drinking in Adulthood in a Rat Model of Depression. World J. Biol. Psychiatry. 2021;22:757–769. doi: 10.1080/15622975.2021.1907717. PubMed DOI
Babinska Z., Ruda-Kucerova J., Amchova P., Merhautova J., Dusek L., Sulcova A. Olfactory Bulbectomy Increases Reinstatement of Methamphetamine Seeking after a Forced Abstinence in Rats. Behav. Brain Res. 2016;297:20–27. doi: 10.1016/j.bbr.2015.09.035. PubMed DOI
Lucas G., Rymar V.V., Du J., Mnie-Filali O., Bisgaard C., Manta S., Lambas-Senas L., Wiborg O., Haddjeri N., Piñeyro G., et al. Serotonin(4) (5-HT(4)) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action. Neuron. 2007;55:712–725. doi: 10.1016/j.neuron.2007.07.041. PubMed DOI
Padilla K.M., Quintanar-Setephano A., López-Vallejo F., Berumen L.C., Miledi R., García-Alcocer G. Behavioral Changes Induced through Adenosine A2A Receptor Ligands in a Rat Depression Model Induced by Olfactory Bulbectomy. Brain Behav. 2018;8:e00952. doi: 10.1002/brb3.952. PubMed DOI PMC
Primeaux S.D., Wilson M.A., Wilson S.P., Guth A.N., Lelutiu N.B., Holmes P.V. Herpes Virus-Mediated Preproenkephalin Gene Transfer in the Ventral Striatum Mimics Behavioral Changes Produced by Olfactory Bulbectomy in Rats. Brain Res. 2003;988:43–55. doi: 10.1016/S0006-8993(03)03337-7. PubMed DOI
Romeas T., Morissette M.C., Mnie-Filali O., Pineyro G., Boye S.M. Simultaneous Anhedonia and Exaggerated Locomotor Activation in an Animal Model of Depression. Psychopharmacology. 2009;205:293–303. doi: 10.1007/s00213-009-1539-y. PubMed DOI
Shin M.-S., Park S.-S., Lee J.-M., Kim T.-W., Kim Y.-P. Treadmill Exercise Improves Depression-like Symptoms by Enhancing Serotonergic Function through Upregulation of 5-HT1A Expression in the Olfactory Bulbectomized Rats. J. Exerc. Rehabil. 2017;13:36–42. doi: 10.12965/jer.1734918.459. PubMed DOI PMC
Xu J., Xu H., Liu Y., He H., Li G. Vanillin-Induced Amelioration of Depression-like Behaviors in Rats by Modulating Monoamine Neurotransmitters in the Brain. Psychiatry Res. 2015;225:509–514. doi: 10.1016/j.psychres.2014.11.056. PubMed DOI
Zhang X., Du Q., Liu C., Yang Y., Wang J., Duan S., Duan J. Rhodioloside Ameliorates Depressive Behavior via Up-Regulation of Monoaminergic System Activity and Anti-Inflammatory Effect in Olfactory Bulbectomized Rats. Int. Immunopharmacol. 2016;36:300–304. doi: 10.1016/j.intimp.2016.05.008. PubMed DOI
Gupta D., Radhakrishnan M., Thangaraj D., Kurhe Y. Antidepressant and Anti-Anxiety like Effects of 4i (N-(3-Chloro-2-Methylphenyl) Quinoxalin-2-Carboxamide), a Novel 5-HT3 Receptor Antagonist in Acute and Chronic Neurobehavioral Rodent Models. Eur. J. Pharmacol. 2014;735:59–67. doi: 10.1016/j.ejphar.2014.04.008. PubMed DOI
Jindal A., Mahesh R., Bhatt S. Etazolate, a Phosphodiesterase-4 Enzyme Inhibitor Produces Antidepressant-like Effects by Blocking the Behavioral, Biochemical, Neurobiological Deficits and Histological Abnormalities in Hippocampus Region Caused by Olfactory Bulbectomy. Psychopharmacology. 2014;105:63–70. doi: 10.1007/s00213-014-3705-0. PubMed DOI
Jindal A., Mahesh R., Bhatt S. Type 4 Phosphodiesterase Enzyme Inhibitor, Rolipram Rescues Behavioral Deficits in Olfactory Bulbectomy Models of Depression: Involvement of Hypothalamic-Pituitary-Adrenal Axis, CAMP Signaling Aspects and Antioxidant Defense System. Pharmacol. Biochem. Behav. 2015;132:20–32. doi: 10.1016/j.pbb.2015.02.017. PubMed DOI
Rinwa P., Kumar A. Panax Quinquefolium Involves Nitric Oxide Pathway in Olfactory Bulbectomy Rat Model. Physiol. Behav. 2014;129:142–151. doi: 10.1016/j.physbeh.2014.02.037. PubMed DOI
Chambliss H.O., Van Hoomissen J.D., Holmes P.V., Bunnell B.N., Dishman R.K. Effects of Chronic Activity Wheel Running and Imipramine on Masculine Copulatory Behavior after Olfactory Bulbectomy. Physiol. Behav. 2004;82:593–600. doi: 10.1016/j.physbeh.2004.04.064. PubMed DOI
Slattery D.A., Markou A., Cryan J.F. Evaluation of Reward Processes in an Animal Model of Depression. Psychopharmacology. 2007;190:555–568. doi: 10.1007/s00213-006-0630-x. PubMed DOI
Stepanichev M., Markov D., Pasikova N., Gulyaeva N. Behavior and the Cholinergic Parameters in Olfactory Bulbectomized Female Rodents: Difference between Rats and Mice. Behav. Brain Res. 2016;297:5–14. doi: 10.1016/j.bbr.2015.09.033. PubMed DOI
Otmakhova N.A., Gurevich E.V., Katkov Y.A., Nesterova I.V., Bobkova N.V. Dissociation of Multiple Behavioral Effects between Olfactory Bulbectomized C57Bl/6J and DBA/2J Mice. Physiol. Behav. 1992;52:441–448. doi: 10.1016/0031-9384(92)90329-Z. PubMed DOI
Wu H.H., Wang S. Strain Differences in the Chronic Mild Stress Animal Model of Depression. Behav. Brain Res. 2010;213:94–102. doi: 10.1016/j.bbr.2010.04.041. PubMed DOI
O’Mahony C.M., Clarke G., Gibney S., Dinan T.G., Cryan J.F. Strain Differences in the Neurochemical Response to Chronic Restraint Stress in the Rat: Relevance to Depression. Pharmacol. Biochem. Behav. 2011;97:690–699. doi: 10.1016/j.pbb.2010.11.012. PubMed DOI
Gieryk A., Ziolkowska B., Solecki W., Kubik J., Przewlocki R. Forebrain PENK and PDYN Gene Expression Levels in Three Inbred Strains of Mice and Their Relationship to Genotype-Dependent Morphine Reward Sensitivity. Psychopharmacology. 2010;208:291–300. doi: 10.1007/s00213-009-1730-1. PubMed DOI
Brand T., Spanagel R., Schneider M. Decreased Reward Sensitivity in Rats from the Fischer344 Strain Compared to Wistar Rats Is Paralleled by Differences in Endocannabinoid Signaling. PLoS ONE. 2012;7:e31169. doi: 10.1371/journal.pone.0031169. PubMed DOI PMC
Deiana S., Fattore L., Spano M.S., Cossu G., Porcu E., Fadda P., Fratta W. Strain and Schedule-Dependent Differences in the Acquisition, Maintenance and Extinction of Intravenous Cannabinoid Self-Administration in Rats. Neuropharmacology. 2007;52:646–654. doi: 10.1016/j.neuropharm.2006.09.007. PubMed DOI
Marusich J.A., McCuddy W.T., Beckmann J.S., Gipson C.D., Bardo M.T. Strain Differences in Self-Administration of Methylphenidate and Sucrose Pellets in a Rat Model of ADHD. Behav. Pharmacol. 2011;22:794–804. doi: 10.1097/FBP.0b013e32834d623e. PubMed DOI PMC
Manduca A., Campolongo P., Palmery M., Vanderschuren L.J.M.J., Cuomo V., Trezza V. Social Play Behavior, Ultrasonic Vocalizations and Their Modulation by Morphine and Amphetamine in Wistar and Sprague-Dawley Rats. Psychopharmacology. 2014;231:1661–1673. doi: 10.1007/s00213-013-3337-9. PubMed DOI
Paré W.P. Investigatory Behavior of a Novel Conspecific by Wistar Kyoto, Wistar and Sprague-Dawley Rats. Brain Res. Bull. 2000;53:759–765. doi: 10.1016/S0361-9230(00)00362-2. PubMed DOI
Ruda-Kucerova J., Zanda M.T., Amchova P., Fratta W., Fattore L. Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized Rats. Front. Behav. Neurosci. 2018;12:255. doi: 10.3389/fnbeh.2018.00255. PubMed DOI PMC
Stock H.S., Ford K., Wilson M.A. Gender and Gonadal Hormone Effects in the Olfactory Bulbectomy Animal Model of Depression. Pharmacol. Biochem. Behav. 2000;67:183–191. doi: 10.1016/S0091-3057(00)00318-X. PubMed DOI
Dalla C., Pitychoutis P.M., Kokras N., Papadopoulou-Daifoti Z. Sex Differences in Response to Stress and Expression of Depressive-Like Behaviours in the Rat. In: Neill J.C., Kulkarni J., editors. Biological Basis of Sex Differences in Psychopharmacology. Springer; Berlin/Heidelberg, Germany: 2011. pp. 97–118. Current Topics in Behavioral Neurosciences. PubMed
Fattore L., Spano M.S., Altea S., Angius F., Fadda P., Fratta W. Cannabinoid Self-Administration in Rats: Sex Differences and the Influence of Ovarian Function. Br. J. Pharmacol. 2007;152:795–804. doi: 10.1038/sj.bjp.0707465. PubMed DOI PMC
Fattore L., Spano M., Altea S., Fadda P., Fratta W. Drug- and Cue-Induced Reinstatement of Cannabinoid-Seeking Behaviour in Male and Female Rats: Influence of Ovarian Hormones. Br. J. Pharmacol. 2010;160:724–735. doi: 10.1111/j.1476-5381.2010.00734.x. PubMed DOI PMC
Castelli M.P., Fadda P., Casu A., Spano M.S., Casti A., Fratta W., Fattore L. Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing to Drug Addiction: Effect of Ovarian Hormones. Curr. Pharm. Des. 2014;20:2100–2113. doi: 10.2174/13816128113199990430. PubMed DOI
Pisanu A., Lo Russo G., Talani G., Bratzu J., Siddi C., Sanna F., Diana M., Porcu P., De Luca M.A., Fattore L. Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences. Biomedicines. 2022;10:2336. doi: 10.3390/biomedicines10102336. PubMed DOI PMC
Ruda-Kucerova J., Amchova P., Havlickova T., Jerabek P., Babinska Z., Kacer P., Syslova K., Sulcova A., Sustkova-Fiserova M. Reward Related Neurotransmitter Changes in a Model of Depression: An in Vivo Microdialysis Study. World J. Biol. Psychiatry. 2015;16:521–535. doi: 10.3109/15622975.2015.1077991. PubMed DOI
Kelly J.P., Wrynn A.S., Leonard B.E. The Olfactory Bulbectomized Rat as a Model of Depression: An Update. Pharmacol. Ther. 1997;74:299–316. doi: 10.1016/S0163-7258(97)00004-1. PubMed DOI
Cabeza de Vaca S., Carr K.D. Food restriction enhances the central rewarding effect of abused drugs. J. Neurosci. 1998;18:7502–7510. doi: 10.1523/JNEUROSCI.18-18-07502.1998. PubMed DOI PMC
Fattore L., Cossu G., Martellotta C.M., Fratta W. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology. 2001;156:410–416. doi: 10.1007/s002130100734. PubMed DOI
Ruda-Kucerova J., Amchova P., Babinska Z., Dusek L., Micale V., Sulcova A. Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats. Front. Psychiatry. 2015;6:91. doi: 10.3389/fpsyt.2015.00091. PubMed DOI PMC
Anker J.J., Zlebnik N.E., Navin S.F., Carroll M.E. Responding during Signaled Availability and Nonavailability of Iv Cocaine and Food in Rats: Age and Sex Differences. Psychopharmacology. 2011;215:785–799. doi: 10.1007/s00213-011-2181-z. PubMed DOI PMC
Contini A., Sanna F., Maccioni P., Colombo G., Argiolas A. Comparison between Male and Female Rats in a Model of Self-Administration of a Chocolate-Flavored Beverage: Behavioral and Neurochemical Studies. Behav. Brain Res. 2018;344:28–41. doi: 10.1016/j.bbr.2018.02.004. PubMed DOI
Jastrzębska J., Frankowska M., Suder A., Wydra K., Nowak E., Filip M., Przegaliński E. Effects of Escitalopram and Imipramine on Cocaine Reinforcement and Drug-Seeking Behaviors in a Rat Model of Depression. Brain Res. 2017;1673:30–41. doi: 10.1016/j.brainres.2017.07.016. PubMed DOI
Gawlińska K., Jastrzębska J., Gamberini S., Gawliński D., Pieniążek R., Suder A., Wydra K., Frankowska M. The Impact of GABAB Receptors and Their Pharmacological Stimulation on Cocaine Reinforcement and Drug-Seeking Behaviors in a Rat Model of Depression. Eur. J. Pharmacol. 2020;883:173324. doi: 10.1016/j.ejphar.2020.173324. PubMed DOI
Kelly J.P., Leonard B.E. Effects of Chronic Desipramine on Waiting Behaviour for a Food Reward in Olfactory Bulbectomized Rats. J. Psychopharmacol. 1996;10:153–156. doi: 10.1177/026988119601000211. PubMed DOI
Jastrzębska J., Frankowska M., Smaga I., Hubalewska-Mazgaj M., Suder A., Pieniążek R., Przegaliński E., Filip M. Evaluation of the 5-HT2C Receptor Drugs RO 60-0175, WAY 161503 and Mirtazepine in a Preclinical Model of Comorbidity of Depression and Cocaine Addiction. Pharmacol. Rep. 2023;75:99–118. doi: 10.1007/s43440-022-00428-2. PubMed DOI PMC